| scholarly article | Q13442814 |
| P2093 | author name string | Yu Zhang | |
| Xuan Wu | |||
| Hongning Wang | |||
| Long Zhou | |||
| Rong Xiang | |||
| Lei Zuo | |||
| Yan Lai | |||
| Xiwen Zhai | |||
| Xueran Mei | |||
| Zhuangzhuang Kang | |||
| P2860 | cites work | Progress and challenges toward the development of vaccines against avian infectious bronchitis | Q27015837 |
| Immunological concepts of vaccine adjuvant activity | Q28141017 | ||
| Coronavirus IBV: partial amino terminal sequencing of spike polypeptide S2 identifies the sequence Arg-Arg-Phe-Arg-Arg at the cleavage site of the spike precursor propolypeptide of IBV strains Beaudette and M41. | Q54148286 | ||
| Complete nucleotide sequence of Newcastle disease virus: evidence for the existence of a new genus within the subfamily Paramyxovirinae | Q31915388 | ||
| Subviral particle as vaccine and vaccine platform | Q33812653 | ||
| Assembly and biological and immunological properties of Newcastle disease virus-like particles | Q33826688 | ||
| A nonreplicating subunit vaccine protects mice against lethal Ebola virus challenge. | Q34029668 | ||
| Evidence for mixed membrane topology of the newcastle disease virus fusion protein | Q34466955 | ||
| Toll-like receptors and their ligands. | Q35017541 | ||
| Evaluation of the Newcastle disease virus F and HN proteins in protective immunity by using a recombinant avian paramyxovirus type 3 vector in chickens | Q35077454 | ||
| Virus-like particles as immunogens | Q35295832 | ||
| Nucleocapsid-independent assembly of coronavirus-like particles by co-expression of viral envelope protein genes. | Q35848639 | ||
| Chimeric Bivalent Virus-Like Particle Vaccine for H5N1 HPAI and ND Confers Protection against a Lethal Challenge in Chickens and Allows a Strategy of Differentiating Infected from Vaccinated Animals (DIVA). | Q36132477 | ||
| Genetic and molecular biological analysis of protein-protein interactions in coronavirus assembly | Q36621999 | ||
| Coronavirus avian infectious bronchitis virus | Q36734185 | ||
| Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design | Q37792984 | ||
| Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development | Q38059059 | ||
| Virus-like particles that display Zika virus envelope protein domain III induce potent neutralizing immune responses in mice | Q38156841 | ||
| Bioengineering virus-like particles as vaccines | Q38172045 | ||
| Newcastle disease virus: current status and our understanding | Q38192846 | ||
| Virus-like particle vaccine confers protection against a lethal newcastle disease virus challenge in chickens and allows a strategy of differentiating infected from vaccinated animals | Q38320531 | ||
| Efficient assembly and release of SARS coronavirus-like particles by a heterologous expression system. | Q39272520 | ||
| Assembly and immunogenicity of coronavirus-like particles carrying infectious bronchitis virus M and S proteins | Q39338278 | ||
| Assembly of spikes into coronavirus particles is mediated by the carboxy-terminal domain of the spike protein | Q39588413 | ||
| Identification of amino acids relevant to three antigenic determinants on the fusion protein of Newcastle disease virus that are involved in fusion inhibition and neutralization | Q40131073 | ||
| Recombinant Newcastle disease virus expressing the infectious bronchitis virus S1 gene protects chickens against Newcastle disease virus and infectious bronchitis virus challenge | Q40273756 | ||
| Phylogenetic analysis reveals a low rate of homologous recombination in negative-sense RNA viruses | Q40550213 | ||
| Role of fusion protein cleavage site in the virulence of Newcastle disease virus | Q40612116 | ||
| Genome sequence and origin analyses of the recombinant novel IBV virulent isolate SAIBK2. | Q40701455 | ||
| Assembly and immunogenicity of baculovirus-derived infectious bronchitis virus-like particles carrying membrane, envelope and the recombinant spike proteins | Q40954441 | ||
| Serotype shift of a 793/B genotype infectious bronchitis coronavirus by natural recombination | Q41113950 | ||
| Protection of chickens from Newcastle disease by vaccination with a linear plasmid DNA expressing the F protein of Newcastle disease virus | Q41193743 | ||
| The spike protein of infectious bronchitis virus is retained intracellularly by a tyrosine motif | Q42081331 | ||
| A new genotype of nephropathogenic infectious bronchitis virus circulating in vaccinated and non-vaccinated flocks in China | Q44401437 | ||
| A vaccine candidate of attenuated genotype VII Newcastle disease virus generated by reverse genetics | Q45387833 | ||
| F gene recombination between genotype II and VII Newcastle disease virus | Q45399252 | ||
| Synthesis and assembly of hepatitis B virus surface antigen particles in yeast | Q45793098 | ||
| Coronavirus IBV: virus retaining spike glycopolypeptide S2 but not S1 is unable to induce virus-neutralizing or haemagglutination-inhibiting antibody, or induce chicken tracheal protection | Q45836578 | ||
| Immunogenicity and protective efficacy of recombinant fiber-2 protein in protecting SPF chickens against fowl adenovirus 4. | Q50208592 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bronchitis | Q173022 |
| Newcastle disease | Q11903425 | ||
| infectious disease | Q18123741 | ||
| Newcastle disease virus | Q327082 | ||
| infectious bronchitis virus | Q69459596 | ||
| P304 | page(s) | 254 | |
| P577 | publication date | 2019-03-13 | |
| P1433 | published in | Viruses | Q7935305 |
| P1476 | title | Construction and Immunogenicity of Novel Chimeric Virus-Like Particles Bearing Antigens of Infectious Bronchitis Virus and Newcastle Disease Virus | |
| P478 | volume | 11 |
Search more.